Results of a phase II trial of cetuximab plus capecitabine/irinotecan as first-line therapy for patients with advanced and/or metastatic colorectal cancer

Thomas Cartwright, Paul Kuefler, Allen Cohn, William Hyman, Maury Berger, Donald Richards, Svetislava Vukelja, John E. Nugent, Robert L. Ruxer, Kristi A. Boehm, Lina Asmar

Research output: Contribution to journal › Article › peer-review